ArticleJID innovations : skin science from molecules to population health2026
Initial preclinical investigation of aclarubicin treatment in primary cutaneous T-cell lymphoma cells.
Fenna J de Bie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.